Sherry â€" Shown to have Health BenefitsMarch 17, 2004New research published in Journal of the Science of Food and Agriculture suggests that sherry may have the same health benefits as red wine. Sherry contains antioxidants that help control cholesterol levels, say Spanish scientists. Studies by researchers at University of Seville have shown that sherry, like red wine, contains antioxidants called polyphenols, which reduce the occurrence of coronary artery disease. They work by preventing the oxidation of Low-Density Lipoproteins (LDL), which is associated with the disease. Drinking sherry can also increase the body's production of High-Density Lipoprotein (HDL) cholesterol, which is associated with longevity and a decreased incidence of coronary artery disease. 'Sherry is widely consumed, especially in Spain and the UK, and we have shown that its moderate intake decreased total cholesterol and increased HDL-cholesterol,' says Juan M. Guerrero, researcher on the paper. To test the effects, rats were given daily quantities of sherry equivalent of a 150ml serving in an adult weighing 70kg. Control rats were given the same amount of either water or ethanol in water. Intake of sherry every day at 16:00 over two months did not affect the weight of the rats or have any other significant impact on other metabolic processes - but it did result in the decrease in serum total (bad) cholesterol and an increase in HDL (good) cholesterol. Four of the most commonly produced sherries in Andalucia, Spain, bearing the generic names Oloroso, Manzanilla, Fino and Amontillado, were tested. All four types had the same effect. 'As a general rule, moderate consumption of red wine exerts beneficial effects for health. In our research, the beneficial effects of red wine can be extensive to sherry wines,' says Guerrero. Society of Chemical Industry |
|||||||||||||||||||||
| Related Cholesterol Current Events and Cholesterol News Articles Study suggests dentists can identify patients at risk for fatal cardiovascular event A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. Researchers identify the three killer indicators that are even worse than high cholesterol Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality. Can charcoal fight heart disease in kidney patients? Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Statins show dramatic drug and cell dependent effects in the brain Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. Web-based nutrition program reduces health care costs for employees with cardiac risk factors Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. These findings appear in the current issue of the Journal of Medical Internet Research. Cholesterol-lowering medicines may be effective against cancer Statins lower cholesterol by blocking certain enzymes involved in our metabolism. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. Adding ezetimibe to atorvastatin improves lipid control Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone. More Cholesterol Current Events and Cholesterol News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||